Back to top
more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$25.77 USD

25.77
453,559

-0.03 (-0.12%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $25.77 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Despite Fast-paced Momentum, Patterson Cos. (PDCO) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Patterson Cos. (PDCO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

SentinelOne (S) to Report Q2 Earnings: What's in the Cards?

SentinelOne's (S) second-quarter fiscal 2024 results are likely to reflect the benefits of an expanding clientele amid challenging macroeconomic conditions.

Should You Buy Patterson Companies (PDCO) Ahead of Earnings?

Patterson Companies (PDCO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

OPKO Health's (OPK) potential in RAYALDEE raises optimism about the stock.

Is a Beat Likely for Cooper Companies (COO) in Q3 Earnings?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Medtronic's (MDT) Inceptiv Spinal Cord Stimulator Gets CE Mark

Medtronic's (MDT) Inceptiv SCS System is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals.

BrainsWay (BWAY) Expands Foothold in Taiwan With Deep TMS

The collaboration between BrainsWay (BWAY) and Unison Healthcare Group signifies a coordinated effort to enhance access and awareness of Deep TMS in Taiwan.

LabCorp (LH) Suffers From Lower COVID Test Sales, Macro Woes

Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues.

VMware (VMW) to Report Q2 Earnings: What's in the Cards?

VMware's (VMW) second-quarter fiscal 2024 performance is likely to have reflected the benefits of a strong portfolio and expanding partner base.

Broadcom (AVGO) to Report Q3 Earnings: What's in the Cards?

Broadcom's (AVGO) fiscal third-quarter results are likely to reflect strong networking solutions revenues, driven by robust adoption of Tomahawk 4 and Jericho switches.

CrowdStrike (CRWD) to Report Q2 Earnings: What's in Store?

CrowdStrike's (CRWD) second-quarter results are likely to reflect the benefits of the strong demand for its security solutions, contributions from collaborations and newly added customers.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Salesforce (CRM) to Report Q2 Earnings: What's in the Offing?

While digital transformation and the growing adoption of generative AI-enabled solutions are likely to have boosted Salesforce's (CRM) top line in Q2, cost-cutting initiatives are expected to have driven the bottom line.

OKTA Gears Up to Report Q2 Earnings: What's in the Cards?

OKTA's second-quarter fiscal 2024 results are expected to reflect the continued adoption of Workforce and Customer Identity solutions.

Charles River (CRL) Collaborates With Fondazione Telethon

Charles River (CRL) is excited about Fondazione Telethon's collaboration to produce HQ plasmid DNA for the lentivirus used in ex vivo gene therapy developed by Fondazione Telethon.

HP Inc. (HPQ) Set to Release Q3 Earnings: What's in Store?

HP Inc.'s (HPQ) third-quarter performance is likely to have been negatively impacted by the weak demand for PCs, high inventory levels and unfavorable currency exchange rates.

Is a Beat Likely for Patterson Companies (PDCO) in Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at both Dental and Animal Health segments.

NextGen (NXGN) to Offer AI-Based Patient Engagement Solutions

NextGen (NXGN), in alliance with Luma Health, is set to offer AI-enhanced solutions for patient communications to ambulatory organizations nationwide.

Catalent (CTLT) to Report Q4 Earnings: What's in the Cards?

Catalent's (CTLT) Q4 results are likely to be affected by soft segmental performances.

Masimo's (MASI) Stork Baby Monitor Now Available Across U.S.

The latest U.S. availability of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.

Here's Why You Should Retain Hologic (HOLX) Stock for Now

Investors are optimistic about Hologic (HOLX) on the expanded global installed base of more than 3,250 Panthers instruments, representing the catalyst for sustained growth.

Veeva Systems (VEEV) to Support Civica Rx Quality Control

Veeva Systems' (VEEV) Vault LIMS will streamline internal testing and manufacturing while promoting lead time adherence.

Hewlett Packard (HPE) to Report Q3 Earnings: What's in Store?

The growing demand for cloud services amid the ongoing digital transformation trend is likely to aid Hewlett Packard's (HPE) third-quarter fiscal 2023 results.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.